MONECO Advisors’s Sanofi SNY Stock Holding History

MONECO Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,162	Closed	-$201K	–	613
2026 Q1	$201K	Buy	+4,162	New	+$194K	0.02%	507
2025 Q2	–	Sell	-3,851	Closed	-$214K	–	480
2025 Q1	$214K	Buy	+3,851	New	+$208K	0.02%	432
2023 Q3	–	Sell	-3,895	Closed	-$210K	–	351
2023 Q2	$210K	Sell	3,895 -35	-0.9%	-$1.88K	0.06%	316
2023 Q1	$214K	Buy	+3,930	New	+$191K	0.06%	300

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

MONECO Advisors's SNY Position: Q2 2026 in Review

MONECO Advisors sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,162 shares — an estimated $201K sold.

MONECO Advisors first reported a position in SNY in Q1 2023 and held it in 4 quarters. The position peaked at $214K in Q1 2023. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

MONECO Advisors reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
MONECO Advisors sold 4,162 Sanofi shares in Q2 2026, an estimated $201K.
MONECO Advisors first reported a position in Sanofi in Q1 2023 and held it in 4 quarters.
MONECO Advisors's Sanofi position peaked at $214K in Q1 2023.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.